Oxford Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Oxford Asset Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-447,200	Closed	-$80.4M	–	2032
2017 Q3	$80.4M	Buy	+447,200	New	+$62.3M	1.55%	9
2016 Q4	–	Sell	-25,453	Closed	-$1.42M	–	937
2016 Q3	$1.42M	Buy	+25,453	New	+$1.42M	0.04%	457
2016 Q1	–	Sell	-8,241	Closed	-$516K	–	989
2015 Q4	$516K	Buy	+8,241	New	+$580K	0.01%	666

Oxford Asset Management's KITE Position: Q4 2017 in Review

Oxford Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 447,200 shares — an estimated $80.4M sold.

Oxford Asset Management first reported a position in KITE in Q4 2015 and held it in 3 quarters. The position peaked at $80.4M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Oxford Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Oxford Asset Management sold 447,200 Kite Pharma, Inc. shares in Q4 2017, an estimated $80.4M.
Oxford Asset Management first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 3 quarters.
Oxford Asset Management's Kite Pharma, Inc. position peaked at $80.4M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Oxford Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.